My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mind Medicine (MindMed) Inc. - Common Shares (NQ:MNMD)

10.67 +0.90 (+9.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
33 34 Next >
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
Major Psychedelic Drug Stocks Went Up 7% This Week; Still Down 46% YTD
The 6 major psychedelic stocks researching the treatment of a variety of mental illnesses were UP 7% this week and are UP 3 % in the last 6 weeks. The 6 therapy clinic stocks went UP 3% this week and... 
Via Talk Markets
Psychedelic Stock Gainers And Losers From December 2, 2022
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 1, 2022
 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 30, 2022
 
Via Benzinga
Mind Medicine’s Bad Trip Won’t End Anytime Soon
Trouble abounds as Mind Medicine proposes a huge sale of MNMD stock shares and an activist investor threatens the company's board. 
Via InvestorPlace
Revive Therapeutics, Seelos Therapeutics Among Top Psychedelic Movers Of Today
 
Via Benzinga
Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
 
Via Benzinga
7 F-Rated Stocks to Sell Before We Reach Christmas
While you’re looking for the perfect holiday bargains, this is also an ideal time to clear your portfolio from F-rated stocks to sell. 
Via InvestorPlace
Psychedelic Stock Gainers And Losers From November 25, 2022
 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 24, 2022
 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 23, 2022
 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 22, 2022
 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 21, 2022
 
Via Benzinga
Psychedelic Drug Stocks Index Continued To Decline Last Week
This article highlights the performances of the 6 constituents in the munKNEE Psychedelic Drug Stocks Index last week and in the last 3 weeks and the extent to which each company is likely to encounter... 
Via Talk Markets
Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
 
Via Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 16, 2022
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
Upgrades 
Via Benzinga
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup
Colorado Voters Approve Initiative To Legalize And Regulate Psychedelics 
Via Benzinga
Activist Investor Informs MindMed of Financial Misstatements, Questions Internal Controls
From Concerned Shareholders of Company MindMed
Via GlobeNewswire
Clinical Stage Psychedelic Stock Index Up 6%; Therapy Clinic Stocks Down 8%
We highlight the performance of our Psychedelic Drug Stocks Index and the 6 psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of different psychedelic... 
Via Talk Markets
MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials
Clinical-stage biotech company Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) reported its financial results and updated on its programs pipeline of the third quarter ended September 30, 2022. 
Via Benzinga
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 12.17% at $10.05 
Via Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 7.91% at $9.96 LOSERS: 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 8, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 3.85% at $0.14 
Via Benzinga
The Psychedelic Drug Stocks Index Continued To Plummet Last Week
In total, the Psychedelic Drug Stock Index went down 5.8% last week and is now down 64.9% YTD. 
Via Talk Markets
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 4.10% at $0.44 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 3, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.80% at $10.27 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.